NEW YORK, May 07, 2018 -- Safirstein Metcalf LLP and HGT Law remind investors that a shareholder “opt-out” lawsuit (“Lawsuit”) has been filed on behalf of a group of retail investors (“Investors”) against Valeant Pharmaceuticals International, Inc. (“Valeant”) and its senior officers for violations of federal securities laws and invite investors to contact the firms.
Previously, on June 24, 2016, a class action complaint was filed in the U.S. District Court for the District of New Jersey, on behalf of a class consisting of all purchasers of the common stock of Valeant (“Class Action”). More than twenty lawsuits have been filed on behalf of institutional investors who have decided to opt out of the Class Action to directly pursue their own claims. To date, the Lawsuit commenced by Safirstein Metcalf LLP and HGT Law is the only opt-out lawsuit that has been filed on behalf of retail investors.
A copy of the complaint filed by Safirstein Metcalf LLP and HGT Law on behalf of the Investors can be found here. For more information on opt-out lawsuits, see our publication here.
If you purchased Valeant common stock during the period from January 4, 2013 through March 15, 2016 and suffered losses of more than $200,000, then you may wish to consider opting out of the existing class action and joining the Lawsuit. A number of large institutional investors such as T. Rowe Price, Blackrock and Prudential Insurance Company have already opted out of the class action. If you would like to learn about the options available to you, please call 1-800-221-0015, email [email protected] or visit www.valeantshareholderlitigation.com
Company: Valeant Pharmaceuticals International, Inc.
Exchange: NYSE
Ticker: VRX
Class Period: 01/04/2013 – 03/15/2016
About Safirstein Metcalf LLP and HGT Law
Safirstein Metcalf LLP focuses its practice on shareholder rights. The law firm also practices in the areas of antitrust and consumer protection. All of the Firm’s legal endeavors are rooted in its core mission: provide investor and consumer protection.
HGT Law is a boutique commercial litigation firm based in New York. The firm focuses on representing investors in securities litigation and corporate governance/derivative litigation.
Attorney advertising. Prior results do not guarantee a similar outcome.
Safirstein Metcalf LLP
Peter Safirstein, Esq.
Safirstein Metcalf LLP
The Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118


Citigroup Private Bank Appoints Chad Reddy as West Market Executive in North America
Qualcomm to Invest $150 Million in India AI Startups, Strengthening Presence in Growing Market
Microsoft Responds to ICE Surveillance Concerns Amid Azure Cloud Expansion
European IT Hardware Stocks to Watch as Gaming Demand Outpaces Smartphones, Says BofA
Microsoft Plans $50 Billion AI Investment to Accelerate Growth in the Global South
Amazon Surpasses Walmart in Annual Revenue, Signaling a New Era in Retail Competition
Reese’s Peanut Butter Cup Recipe Debate: Hershey Responds as Cocoa Prices Shift
Stock Market Movers: NVIDIA and Meta Expand AI Partnership as Cadence Surges on Earnings
YouTube Outage Disrupts Thousands Worldwide as Recommendation System Fails
Yotta to Build $2 Billion AI Data Centre Hub in India with Nvidia Blackwell Ultra Chips
Freedom Finance and Binance Join Forces in Digital Assets
OpenAI Nears $100 Billion Funding Round at $850 Billion Valuation: Bloomberg Report
Mark Zuckerberg Testifies in Youth Social Media Addiction Trial Over Instagram Policies
Boeing Secures 50 737 MAX Jet Order from Vietnam Airlines Amid Expanding Global Demand
Meta Platforms Cuts Equity Awards Again Amid Massive AI Investment Push 



